How to Get Ruconest (C1 Esterase Inhibitor) Covered by Blue Cross Blue Shield in Pennsylvania: Appeals Guide 2025
Quick Answer: Getting Ruconest Covered in Pennsylvania
Blue Cross Blue Shield in Pennsylvania typically requires prior authorization for Ruconest (C1 esterase inhibitor [recombinant]) used to treat hereditary angioedema (HAE) acute attacks. The fastest path to approval: Submit a complete prior authorization with documented HAE diagnosis, attack history, and clinical justification.